Johnson & Johnson’s Potential Covid-19 Vaccine Begins Phase 3 Trials

Johnson & Johnson’s vaccine candidate, which would only require a single dose, enters phase 3 trials, which would be large-scale involving 60,000 participants. American pharmaceutical Johnson & Johnson has entered its potential COVID-19 vaccine to the last stage of clinical trials. Unlike the other immunization currently under development, the company’s […]